Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metabolic Effects of Uric Acid and Gender Differences
NCT03076684Phase 1Withdrawn
- Sponsor
- University of Missouri
- Start
- Mar 2017
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of allopurinol in hyperuricemia (3 arms), sponsored by University of Missouri. Primary endpoint: Vessel stiffness at 4 months. Planned start Mar 2017; status: withdrawn.
02
Drugs
allopurinol
03
Conditions
hyperuricemia
Beyond the preview
Go deeper on NCT03076684.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03076684.